Chengdu Kanghong Pharmaceutical Group Co., Ltd
Chengdu Kanghong Pharmaceutical Group Co., Ltd., commonly referred to as Kanghong, is a leading player in the pharmaceutical industry, headquartered in Chengdu, China. Established in 1998, the company has made significant strides in the development and production of innovative medical products, particularly in the fields of ophthalmology and oncology. Kanghong's core offerings include a range of high-quality pharmaceuticals and medical devices, distinguished by their commitment to research and development. The company has achieved notable market recognition, positioning itself as a trusted provider in both domestic and international markets. With a focus on enhancing patient care, Kanghong continues to expand its operational footprint, contributing to advancements in healthcare solutions.
DitchCarbon Score
How does Chengdu Kanghong Pharmaceutical Group Co., Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Chengdu Kanghong Pharmaceutical Group Co., Ltd's score of 22 is lower than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Chengdu Kanghong Pharmaceutical Group Co., Ltd's reported carbon emissions
Chengdu Kanghong Pharmaceutical Group Co., Ltd, headquartered in China (CN), currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. As of now, Chengdu Kanghong Pharmaceutical Group Co., Ltd does not inherit emissions data from any parent or related organizations, nor does it participate in initiatives such as the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP). This lack of data and commitments suggests that the company may still be in the early stages of developing a comprehensive climate strategy. In the context of the pharmaceutical industry, it is increasingly important for companies to establish clear climate commitments and reduction targets to align with global sustainability goals.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Chengdu Kanghong Pharmaceutical Group Co., Ltd is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
